More
    Guided Solutions - Connecting Talent With Innovation/div>

    VB Spine completes deal to buy AR spine tech from Augmedics

    VB Spine announced that it completed its acquisition of rights to the Xvision Spine System from Augmedics. In February, the company announced an agreement to acquire exclusive rights to the Xvision augmented reality (AR) navigation,...

    VB Spine completes deal to buy AR spine tech from Augmedics

    VB Spine announced that it completed its acquisition of rights to the Xvision Spine System from Augmedics. In February, the company announced an agreement to...

    ProSomnus gets FDA nod for latest sleep apnea therapy device

    ProSomnus announced that it received FDA 510(k) clearance for its RPMO₂ obstructive sleep apnea (OSA) therapy device. San Francisco–based ProSomnus says its clearance marks the...

    Adagio Medical wins FDA IDE to expand ventricular ablation study

    Adagio Medical announced that it received FDA investigational device exemption (IDE) to expand its FULCRUM-VT trial. FULCRUM-VT evaluates the company’s vCLAS cryoablation technology for treating...

    FeelTect launches vein ulcer monitoring study at University of Galway

    FeelTect has kicked off a clinical trial in Ireland to evaluate its wearable, pressure-sensing device for vein ulcers. Researchers at the University of Galway will...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    FeelTect launches vein ulcer monitoring study at University of Galway

    FeelTect has kicked off a clinical trial in Ireland to evaluate its wearable, pressure-sensing device for vein ulcers. Researchers at the University of Galway will...

    Data supports Boston Scientific Watchman FLX in stroke reduction

    Boston Scientific announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system. Watchman FLX, Boston Scientific’s left atrial appendage closure (LAAC) device, reduces...

    iPerf enrolls first patient in study of dual-flow femoral artery cannula

    iPerf announced the first-in-human use of its new dual-flow femoral arterial cannula device. Lyon, France-based iPerf designed its device to integrate an additional flow...

    Providence Medical enrols first patients in CORUS-LX system trial

    Providence Medical Technology has enrolled the first subjects in its prospective, randomised controlled trial (RCT) assessing the CORUS-LX system to treat degenerative lumbosacral disease. The...

    Innovation

    Regulatory Approvals

    VB Spine completes deal to buy AR spine tech from Augmedics

    VB Spine announced that it completed its acquisition of rights to the Xvision Spine System from Augmedics. In February, the company announced an agreement to...

    ProSomnus gets FDA nod for latest sleep apnea therapy device

    ProSomnus announced that it received FDA 510(k) clearance for its RPMO₂ obstructive sleep apnea (OSA) therapy device. San Francisco–based ProSomnus says its clearance marks the...

    Adagio Medical wins FDA IDE to expand ventricular ablation study

    Adagio Medical announced that it received FDA investigational device exemption (IDE) to expand its FULCRUM-VT trial. FULCRUM-VT evaluates the company’s vCLAS cryoablation technology for treating...

    FeelTect launches vein ulcer monitoring study at University of Galway

    FeelTect has kicked off a clinical trial in Ireland to evaluate its wearable, pressure-sensing device for vein ulcers. Researchers at the University of Galway will...

    M&A

    Archives

    Latest articles